Charles River Laboratories | CRL - 应收帐款人



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 11.8B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


应收帐款人 更改 日
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.13B 23.36M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Bruker USD 542.7M 2.2M 2026-03
Cardinal Health USD 13.65B 14M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Cigna USD 26.61B 6.26B 2026-03
Concord Medical Services Hldg CNY 57.36M 40.75M 2025-06
CVS Health USD 40.99B 1.21B 2026-03
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
Elevance Health USD 22.79B 1.25B 2026-03
Humana USD 5.22B 1.95B 2026-03
Illumina USD 738M 116M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
IQVIA Holdings USD 3.38B 52M 2026-03
Laboratory Of America USD 2.45B 189.8M 2026-03
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
McKesson USD 27.99B 228M 2026-03
Merck EUR 4.81B 373M 2026-03
Mettler Toledo International USD 708.21M 70.04M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
Quest Diagnostics USD 1.59B 179M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
UnitedHealth USD 26.59B 3.57B 2026-03
Veradigm USD 175.72M 58.76M 2022-12
Waters USD 1.76B 930.16M 2026-03
West Pharmaceutical Services USD 685.6M 111.2M 2026-03